Ten-year results from NRG Oncology/NSABP B-42: A randomized, double-blinded, placebo-controlled clinical trial of extended adjuvant endocrine therapy with letrozole (L) in postmenopausal women with hormone-receptor plus breast cancer (BC) who have completed previous adjuvant therapy with an aromatase inhibitor (AI)

CANCER RESEARCH

AMER ASSOC CANCER RESEARCH

1. Korea Health Technology RD Project
2. Novartis
3. [U10CA180868]
4. [U10CA180822]
5. [UG1CA189867]